Monday, November 9, 2026

German NGO Struggle for Clean Water in South Sudan

Terry Swartzberg

June 19, 2018

NGO Sign of Hope shows, based on scientific research and analysis, that the oil industry in the state of Unity (South Sudan) pollutes the drinking water and people are poisoned with heavy metals. Photo by: Sign of Hope.
MUNICH, Germany (ViaNews) - VENRO, a group of 120 Germany-based NGOs providing humanitarian and development assistance around the world, produced a report entitled “Uncomfortable partners – from confrontation to cooperation: NGO’S strategies for dealing with companies”. This is an important report because it covers – in-depth – a key subject: how NGOs – the brave Davids of this world – fare when they confront multinationals – today’s Goliaths. The report presents seven case studies, among them: “South Sudan / Sign of Hope / Water Contamination by Petronas – Daimler’s ‘bend but don’t break ’ strategy”. The three pages detail of the Petronas case study shows how the German Humanitarian NGO, Sign of Hope, went through a decade-long struggle to put an end to the contamination of South Sudan’s water by allegedly relentlessly greedy international oil companies. Prime among them: Petronas, which is the Malaysian-owned oil giant. Petronas, in turn, entered into a partnership with Germany’s Daimler AG, a German multinational automotive corporation, in Formula 1 racing and other areas. To achieve its objectives of stopping Petronas’ pollution of water, and of getting medical care and compensation for the loss of life, health, and livelihood suffered by more than 600,000 victims in South Sudan. Sign of Hope initiated what it hoped would be a constructive dialogue with Daimler, which has, after all, committed itself to adhere to the highest of ethical and environmental practices when conducting business. Oil-mudslides flooding South Sudan As the in-depth article revealed, this strategy yielded a series of meetings with representatives of Daimler, of Petronas, and of South Sudanese government. All these, in turn, produced nothing more than lofty and empty promises, convoluted explanations – and – in one very worrying case – a threat from the government. Undeterred by the lack of progress, Sign of Hope has pursued, even stepped up its fight for clean water in South Sudan. This stepping up has taken the form of furthering the enlistment of local stakeholders and the facilitation of their self-organization in an NGO. Leading Rights Groups Reveal How a South Sudan Oil Company Plays a Key Role in Prolonging Conflict “There are sound reasons for our move. The carrying on of the fight by a local NGO sends a powerful message to the people of the country and to the world as a whole. Sign of Hope is happy to play the role of an enabler and supporter,” states Klaus Stieglitz, human rights expert and Vice Chairperson of Sign of Hope.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Cycle: Data Readouts, FDA Decisions and Capital-Allocation Shifts
From late October to January, mid-cap biotechs move through a dense run of events: ESMO and AHA/AASLD data presentations, Q3 earnings, and FDA PDUFA dates for ivonescimab (Nov 14) and lorundrostat (Dec 22). Alongside the regulatory news, companies are changing how they allocate capital: one lowered FY2026 R&D and SG&A guidance and pushed milestones into 2027, one authorized a $400M buyback, and one scheduled a delisting vote (EGM Nov 19, application Jan 25). Value is concentrating in a few binary regulatory and Phase 3 outcomes (Maritime-1 and ECLIPSE 2/3 readouts around Q1 2027), so sentiment is mixed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,558 source documents archived
Query this data → isubstrate.com